Advertisement

Therapie maligner Perikardergüsse

  • H. Riess

Zusammenfassung

In autoptischen Untersuchungen finden sich bei 5–20% der Verstorbenen mit manifesten malignen Erkrankungen Perikardbeteiligungen. Im klinischen Verlauf werden bei bis zu 10% der Patienten mit Malignomen symptomatische maligne Perikardergüsse gefunden.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Mukai K, Shinkai T, Tominaga K et al. (1988) The incidence of secondary tumors of the heart and pericardium: a 10-year study. Jpn J Clin Oncol 18: 195–201PubMedGoogle Scholar
  2. 2.
    Theoligides A (1978) Neoplastic cardiac tamponade. Sem Oncol 5: 181–192Google Scholar
  3. 3.
    Thurber DL, Edwards JE, Achor RWP (1962) Secondary malignant tumors of the pericardium. Circulation 26: 228–241PubMedCrossRefGoogle Scholar
  4. 4.
    Hancock EW (1990) Neoplastic pericardial disease. Cardiol Clin 8: 673–682PubMedGoogle Scholar
  5. 5.
    Flannery FP, Gregoratos G, Corder MP (1975) Pericardial effusions in patients with malignant diseases. Arch Intern Med 135: 976–977PubMedCrossRefGoogle Scholar
  6. 6.
    Okamoto H, Shinkai T, Yamakido M et al. (1993) Cardiac tamponade causes by primary lung cancer and the management of pericardial effusion. Cancer 71: 93–98PubMedCrossRefGoogle Scholar
  7. 7.
    Pencha JW, Knight RK, Rubens RD (1987) Pericardial effusion complicating breast cancer. J Royal Soc Med 80: 490–491Google Scholar
  8. 8.
    Quarishi MA, Costanzi JJ, Hokanson J (1983) The natural history of lung cancer with pericardial metastases. Cancer 51: 750–752Google Scholar
  9. 9.
    Wall TC, Campell PT, O’Connor CM et al. (1992) Diagnosis and management (by subxiphoid pericardiotomy) of large pericardial effusions causing cardiac tamponade. Am J Cardiol 69: 1075–1078PubMedCrossRefGoogle Scholar
  10. 10.
    Sears D, Hajdu SI (1977) The cytologic diagnosis of malignant neoplasm in pleural and peritoneal effusions. Acta Cyto1: 31–85Google Scholar
  11. 11.
    Millaire A, Wurtz A, de Groote R et al. (1992) Malignant pericardial effusions: Usefulness of percardioscopy. Am Heart J 124: 1030–1034Google Scholar
  12. 12.
    Gatenby RA, Hartz HW, Kessler HB (1991) Percutaneous catheter drainage for malignant pericardial effusion. J Vase Intery Radiol 2 (1): 151–155CrossRefGoogle Scholar
  13. 13.
    Musch E, Pandjscheri V, Rieger Jet al. (1992) Intrapleural instillation of mitoxantrone for therapy of malignant effusions. J Cancer Res Clin Oncol 118:R 169Google Scholar
  14. 14.
    Palacios IF, Tuzcu EM, Ziskind AA et al. (1991) Percutaneous ballon pericardial window for patients with malignant pericardial effusion and tamponade. Cathet Cardiovase Diagn 22 (4): 244–249CrossRefGoogle Scholar
  15. 15.
    Ready A, Black J, Lewis R et al. (1992) Laparoscopic pericardial fenestration for malignant pericardial effusion (letter). Lancet 339 (8809): 1609PubMedCrossRefGoogle Scholar
  16. 16.
    Smith FE, Lane M, Hudgins PT (1974) Conservative management of malignant pericardial effusions. Cancer 33: 47–57PubMedCrossRefGoogle Scholar
  17. 17.
    Suhrland LL, Weisberger AS (1965) Intracavitary 5 fluorouracil in malignant effusion. Arch Intern Med 116: 431–433PubMedCrossRefGoogle Scholar
  18. 18.
    Van der Gaast A, Kok TC, Hoggerbrugge von der Linden N et al. (1989) Intrapericardial instillation of bleomycin in the management of malignant pericardial effusion. Eur J Cancer Clin Oncol 25: 1505–1506PubMedCrossRefGoogle Scholar
  19. 19.
    Lissoni P, Sarni S, Ardizzoia A et al. (1992) Intracavitary administration of interleukin-2 as palliative therapy for neoplastic effusions. Tumori 78: 118–120PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • H. Riess

There are no affiliations available

Personalised recommendations